BackAnbio Biotechnology Class A Ordinary Shares Overview

Anbio Biotechnology Class A Ordinary Shares Current Assets

Anbio Biotechnology Class A Ordinary Shares's current assets is $30M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$30.24M
↑ 63.17% YoYΔ $11.71M vs prior year quarter

Peer trimmed avg / median

Loading

Anbio Biotechnology Class A Ordinary Shares Current Assets History

Loading

Anbio Biotechnology Class A Ordinary Shares vs. peers: Current Assets Comparison

Loading

Anbio Biotechnology Class A Ordinary Shares Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anbio Biotechnology Class A Ordinary Shares (NNNN) FAQ

As of the most recent data (December 2025), NNNN shows a current assets of $30M. That compares with $19M in the prior-year period — up 63.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NNNN's current assets is now $30M (was $19M) — a 63.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Anbio Biotechnology Class A Ordinary Shares is outperforming or lagging.

Tracking NNNN's current assets over time shows whether Anbio Biotechnology Class A Ordinary Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $30M That compares with $19M in the prior-year period — up 63.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Anbio Biotechnology Class A Ordinary Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $30M) with ownership activity and broader fundamentals.